Weekly reads: aging & stem cells, FDA disarray, bad stem cell headline of the week
Professor Paul Knoepfler, Ph.D.
It’s been a big couple of weeks of chaotic developments at the FDA including the ousting of CBER director Vinay Prasad. The Sarepta rollercoaster was tied to that. If such recent events are any indication of how the next 3+ years are going to play out at the agency, it’s going to be negative for […] The post Weekly reads: aging & stem cells, FDA disarray, bad stem cell headline of the week appeared first on The Niche .